Biotech

All Articles

Boundless Biography makes 'small' cutbacks 5 months after $100M IPO

.Only 5 months after safeguarding a $100 million IPO, Limitless Biography is presently giving up som...

Halda's $126M will certainly evolve 'secure as well as kill' tumor medicines

.The first phases of oncology R&ampD aren't except intriguing brand new modalities, as well as Halda...

Lykos 'disappointments' not disclosing research offenses along with author

.Psychopharmacology has actually drawn 3 short articles about midstage scientific trial data assessi...

Analysts explore Avidity's DMD succeed, showing distinctions in records

.Avidity Biosciences amazed financiers along with phase 1/2 records in Duchenne muscular dystrophy (...

Actinogen's cortisol blocker stops working phase 2 depression research study

.Actinogen Medical's cortisol blocker has overlooked the primary endpoint of a period 2 research in ...

Bivictrix decides going personal only method to take ADC into clinic

.Antibody-drug conjugates (ADCs) have actually gone to the center of several a billion-dollar biobuc...

TPG tops up funds to $580M for expenditures all over life scientific researches

.Resource supervisor TPG, which has assisted biotechs like Sionna Therapies and also Santa Clam Ana ...

Merck ceases stage 3 TIGIT trial in lung cancer cells for futility

.Merck &amp Co.'s TIGIT plan has actually experienced yet another misfortune. Months after shutterin...

After a difficult year, Exscientia folds up into Recursion

.After a year specified through pipe cuts, the shift of its own chief executive officer as well as d...

Cullinan, after $25M offer, return bispecific to Harbour

.Cullinan Rehab was actually thrilled good enough with Harbour BioMed's bispecific immune reactor th...